|
US570802A
(en)
|
|
1896-11-03 |
|
Nicholas powell horton |
|
US509002A
(en)
|
|
1893-11-21 |
|
Eleotbic bail way |
|
US10905A
(en)
|
|
1854-05-16 |
|
Lath-machine |
|
FR901228A
(fr)
|
1943-01-16 |
1945-07-20 |
Deutsche Edelstahlwerke Ag |
Système d'aimant à entrefer annulaire
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5283173A
(en)
|
1990-01-24 |
1994-02-01 |
The Research Foundation Of State University Of New York |
System to detect protein-protein interactions
|
|
AU655417B2
(en)
|
1990-03-22 |
1994-12-22 |
Salk Institute For Biological Studies, The |
Insect retinoid receptor compositions and methods
|
|
CA2096222C
(en)
|
1990-11-13 |
1998-12-29 |
Stephen D. Lupton |
Bifunctional selectable fusion genes
|
|
US5350674A
(en)
|
1992-09-04 |
1994-09-27 |
Becton, Dickinson And Company |
Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
|
|
WO1994028143A1
(en)
|
1993-05-21 |
1994-12-08 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
ATE293699T1
(de)
|
1995-03-03 |
2005-05-15 |
Syngenta Participations Ag |
Kontrolle der pflanzengenexpression durch rezeptor-vermittelte transaktivation in gegenwart von einem chemischen ligand
|
|
JP3926842B2
(ja)
|
1995-03-08 |
2007-06-06 |
ザ・スクリプス・リサーチ・インステイチユート |
抗原提示系およびｔ−細胞の活性化方法
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
US5885827A
(en)
|
1996-01-23 |
1999-03-23 |
The Regents Of The Universtiy Of California |
Eukaryotic high rate mutagenesis system
|
|
AU734051B2
(en)
|
1996-04-05 |
2001-05-31 |
Salk Institute For Biological Studies, The |
Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
ATE347588T1
(de)
|
1996-05-23 |
2006-12-15 |
Scripps Research Inst |
Systeme zur präsentation von mhc-antigenen der klasse ii und verfahren zur aktivierung von cd4?+-t-lymphozyten
|
|
US6489458B2
(en)
|
1997-03-11 |
2002-12-03 |
Regents Of The University Of Minnesota |
DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
|
|
AU738494B2
(en)
|
1997-07-10 |
2001-09-20 |
Salk Institute For Biological Studies, The |
Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
|
|
US6333318B1
(en)
|
1998-05-14 |
2001-12-25 |
The Salk Institute For Biological Studies |
Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
|
|
US6790662B1
(en)
|
1999-03-12 |
2004-09-14 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method of isolating CD8+ cells, and related hybridoma cells antibodies and polypeptides
|
|
CA2386270A1
(en)
|
1999-10-15 |
2001-04-26 |
University Of Massachusetts |
Rna interference pathway genes as tools for targeted genetic interference
|
|
AU1100201A
(en)
|
1999-10-28 |
2001-05-08 |
Board Of Trustees Of The Leland Stanford Junior University |
Methods of in vivo gene transfer using a sleeping beauty transposon system
|
|
US6326193B1
(en)
|
1999-11-05 |
2001-12-04 |
Cambria Biosciences, Llc |
Insect control agent
|
|
CA2406864A1
(en)
|
2000-02-24 |
2001-08-30 |
Life Technologies Corporation |
Simultaneous stimulation and concentration of cells
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
JP5031967B2
(ja)
|
2000-03-22 |
2012-09-26 |
イントレキソン コーポレーション |
新規エクジソン受容体ベースの誘導性遺伝子発現系
|
|
US20040033600A1
(en)
|
2001-03-21 |
2004-02-19 |
Palli Subba Reddy |
Ecdysone receptor-based inducible gene expression system
|
|
AU2001275474A1
(en)
|
2000-06-12 |
2001-12-24 |
Akkadix Corporation |
Materials and methods for the control of nematodes
|
|
US20020082787A1
(en)
|
2000-07-07 |
2002-06-27 |
Woodworth Robert E. |
Method and apparatus for monitoring a product during shipping, storage and use
|
|
US8105825B2
(en)
|
2000-10-03 |
2012-01-31 |
Intrexon Corporation |
Multiple inducible gene regulation system
|
|
WO2002066613A2
(en)
|
2001-02-20 |
2002-08-29 |
Rheogene Holdings, Inc |
Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system
|
|
US20040071671A1
(en)
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
EP1373470B1
(en)
|
2001-02-20 |
2013-04-24 |
Intrexon Corporation |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
CA2438133C
(en)
|
2001-02-20 |
2015-01-27 |
Rheogene, Inc. |
Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
ES2424812T3
(es)
|
2001-02-20 |
2013-10-08 |
Intrexon Corporation |
Receptores X retinoides quiméricos y su uso en un sistema inducible de expresión génica basado en receptores de ecdisona novedoso
|
|
WO2002081649A2
(en)
|
2001-04-06 |
2002-10-17 |
The Trustees Of The University Of Pennsylvania |
ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
|
|
WO2003027289A1
(en)
|
2001-09-26 |
2003-04-03 |
Rheo Gene Holdings, Inc. |
Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
|
|
CA2459807C
(en)
|
2001-09-26 |
2013-09-03 |
Jianzhong Zhang |
Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
AU2003231048A1
(en)
|
2002-04-22 |
2003-11-03 |
Regents Of The University Of Minnesota |
Transposon system and methods of use
|
|
AU2003271904B2
(en)
|
2002-10-09 |
2009-03-05 |
Adaptimmune Limited |
Single chain recombinant T cell receptors
|
|
US7985739B2
(en)
|
2003-06-04 |
2011-07-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhanced sleeping beauty transposon system and methods for using the same
|
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
|
AU2005250408B2
(en)
|
2004-05-27 |
2010-09-23 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
US8361794B2
(en)
|
2004-06-29 |
2013-01-29 |
Immunocore Limited |
Cells expressing a modified T cell receptor
|
|
US9034650B2
(en)
|
2005-02-02 |
2015-05-19 |
Intrexon Corporation |
Site-specific serine recombinases and methods of their use
|
|
GB0523954D0
(en)
*
|
2005-11-24 |
2006-01-04 |
Ucb Celltech |
Bioassays
|
|
ES2579762T3
(es)
|
2006-03-01 |
2016-08-16 |
Janssen Pharmaceutica N.V. |
Tratamiento del cáncer combinando agente linfo - reductor con CLTs y citoquinas
|
|
BRPI0713272A2
(pt)
*
|
2006-06-12 |
2017-05-02 |
Receptor Biologix Inc |
produtos terapêuticos específicos ao receptor na superfície de pan-células
|
|
CA2665568C
(en)
|
2006-10-04 |
2018-01-09 |
Janssen Pharmaceutica, N.V. |
Preparation of inactivated artificial antigen presenting cells and their use in cell therapies
|
|
BRPI0807952A2
(pt)
|
2007-02-20 |
2014-06-10 |
Anaptysbio Inc |
Sistemas de hipermutação somática
|
|
EP2160461B1
(en)
|
2007-07-04 |
2012-08-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Hyperactive variants of the transposase protein of the transposon system sleeping beauty
|
|
KR101666228B1
(ko)
|
2007-09-28 |
2016-10-13 |
인트렉손 코포레이션 |
생물치료학적 분자를 발현시키기 위한 치료학적 유전자-스위치 작제물 및 생물반응기, 및 이의 용도
|
|
HUE035406T2
(en)
|
2007-10-08 |
2018-05-02 |
Intrexon Corp |
Engineered dendritic cells and uses for the treatment of cancer
|
|
US7985559B2
(en)
|
2007-10-19 |
2011-07-26 |
Amgen Inc. |
Methods of selecting epidermal growth factor receptor (EGFR) binding agents
|
|
CN102575227A
(zh)
|
2008-10-08 |
2012-07-11 |
英特瑞克斯顿股份有限公司 |
表达多种免疫调节剂的工程改造细胞及其应用
|
|
DK2496698T3
(en)
|
2009-11-03 |
2019-04-15 |
Hope City |
TRUNCATED EPIDERIMAL GROWTH FACTOR RECEPTOR (EGFRt) FOR TRUNCATED T-CELL SELECTION
|
|
JP5508625B2
(ja)
|
2009-12-14 |
2014-06-04 |
トヨタ自動車株式会社 |
車両の制御装置及び車両の制御方法
|
|
CA2794196A1
(en)
|
2010-03-23 |
2011-09-29 |
Intrexon Corporation |
Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
|
|
US9331524B1
(en)
|
2010-07-03 |
2016-05-03 |
Best Energy Reduction Technologies, Llc |
Method, system and apparatus for monitoring and measuring power usage
|
|
CN103298489A
(zh)
*
|
2010-10-29 |
2013-09-11 |
伊缪诺金公司 |
新型egfr结合分子及其免疫偶联物
|
|
SG10201600912SA
(en)
|
2011-03-04 |
2016-03-30 |
Intrexon Corp |
Vectors conditionally expressing protein
|
|
JP6850528B2
(ja)
*
|
2012-02-13 |
2021-03-31 |
シアトル チルドレンズ ホスピタル ドゥーイング ビジネス アズ シアトル チルドレンズ リサーチ インスティテュート |
二重特異性キメラ抗原受容体およびその治療的使用
|
|
EP2844267A4
(en)
*
|
2012-04-25 |
2016-02-24 |
Ligacept Llc |
BROAD SPECTRUM ERBB LIGAND BINDING MOLECULES AND METHODS OF USING THE SAME
|
|
WO2014159415A1
(en)
|
2013-03-12 |
2014-10-02 |
Bio-Rad Laboratories, Inc. |
Colloidal coomassie stain
|
|
AU2014268364A1
(en)
|
2013-05-24 |
2015-12-10 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
CN104341504B
(zh)
*
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
|
JP2017501712A
(ja)
|
2013-12-18 |
2017-01-19 |
イントレキソン コーポレーション |
単鎖ｉｌ−１２核酸、ポリペプチド、およびそれらの使用
|
|
EP3656864A1
(en)
|
2014-02-14 |
2020-05-27 |
Board of Regents, The University of Texas System |
Chimeric antigen receptors and methods of making
|
|
US9814215B2
(en)
|
2014-03-11 |
2017-11-14 |
Little Big Cat, Inc. |
Pet toy with telescoping wand with metallic wire
|
|
MX383150B
(es)
|
2014-06-02 |
2025-03-13 |
Us Health |
Receptores quiméricos de antígeno que tienen como diana a cd-19.
|
|
TWI750110B
(zh)
|
2014-07-21 |
2021-12-21 |
瑞士商諾華公司 |
使用人類化抗-ｂｃｍａ嵌合抗原受體治療癌症
|
|
KR20170032244A
(ko)
|
2014-07-26 |
2017-03-22 |
선샤인 레이크 파르마 컴퍼니 리미티드 |
Cdk 저해제로서 2-아미노-피리도[2,3-d]피리미딘-7(8h)-온 유도체 및 그 용도
|
|
TWI805109B
(zh)
|
2014-08-28 |
2023-06-11 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
|
SG11201702295UA
(en)
|
2014-09-22 |
2017-04-27 |
Intrexon Corp |
Improved therapeutic control of heterodimeric and single chain forms of interleukin-12
|
|
AU2015343013B2
(en)
|
2014-11-05 |
2020-07-16 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
|
CA2969456A1
(en)
*
|
2014-12-03 |
2016-06-09 |
Juno Therapeutics, Inc. |
Methods and compositions for adoptive cell therapy
|
|
ES2869972T3
(es)
|
2015-01-26 |
2021-10-26 |
Cellectis |
Sistemas de receptores de antígenos quiméricos dirigidos por mAb para clasificar/agotar células inmunitarias genomanipuladas
|
|
SG11201802912PA
(en)
|
2015-10-10 |
2018-05-30 |
Intrexon Corp |
Improved therapeutic control of proteolytically sensitive, destabilized forms of interleukin-12
|
|
EP4012415A3
(en)
|
2015-12-04 |
2022-12-07 |
Juno Therapeutics, Inc. |
Methods and compositions related to toxicity associated with cell therapy
|
|
SG11201810640RA
(en)
*
|
2016-06-08 |
2018-12-28 |
Intrexon Corp |
Cd33 specific chimeric antigen receptors
|
|
CN108330133B
(zh)
|
2017-01-20 |
2020-06-30 |
上海恒润达生生物科技有限公司 |
靶向cd19嵌合抗原受体并对其双重修饰的方法及其用途
|
|
WO2018197675A1
(en)
|
2017-04-28 |
2018-11-01 |
Julius-Maximilians-Universität Würzburg |
Ror1-specific chimeric antigen receptors (car) with humanized targeting domains
|